CAS 1202400-18-7

Fórmula: C23H36ClN3O4

InChI: InChI=1S/C23H36ClN3O4/c1-15(2)18(26-20(29)25-13-22(5,6)30)19(28)27-12-11-23(31,21(3,4)14-27)16-7-9-17(24)10-8-16/h7-10,15,18,30-31H,11-14H2,1-6H3,(H2,25,26,29)/t18-,23+/m1/s1

Clave InChI: GTDPZONCGOCXOD-JPYJTQIMSA-N

SMILES: CC(C)[C@H](C(=O)N1CC[C@@](C(C1)(C)C)(C2=CC=C(C=C2)Cl)O)NC(=O)NCC(C)(C)O

BMS-817399

CAS: 1202400-18-7

BMS-817399

Fórmula: C₂₃H₃₆ClN₃O₄

Pureza: 99.5%

Peso molecular: 454.0

Ref: 54-BUP12300

BMS-817399

CAS: 1202400-18-7

Ref: IN-DA024BC6

BMS-817399

CAS: 1202400-18-7

BMS-817399: oral CCR1 antagonist with binding and chemotaxis inhibition IC50s, potential for rheumatoid arthritis research.

Fórmula: C₂₃H₃₆ClN₃O₄

Pureza: 99.7%

Forma y color: Solid

Peso molecular: 454.003

Ref: TM-T26861